ALA

SKYX Reports Record Sales of $58.8 Million for 2023 and Fourth Quarter Record Sales of $22.2 Million as it Continues to Enhance its Market Penetration for Both Retail and Pro Segments

Retrieved on: 
Monday, April 1, 2024
ALA, General Electric, Annual report, Tax, NAHB, BelAmi, Acceleration, Partnership, ANSI, International, Sale, Acquisition, National Electrical Code, Consumer Electronics Show, NEC, Investment, Safety, Depreciation, CES, IBS, Lighting, Data aggregation, Marketing, Video game

Generated a record $58.8 million in revenue in 2023, including E-commerce sales, smart home products and advanced plug & play products, as compared to $32,022 in 2022.

Key Points: 
  • Generated a record $58.8 million in revenue in 2023, including E-commerce sales, smart home products and advanced plug & play products, as compared to $32,022 in 2022.
  • Generated a record $22.2 million in revenue in the fourth quarter of 2023.
  • SKYX has started sales to the builder and pro segments and opened over 100 builder and pro accounts during the International Builders’ Show (IBS - NAHB) in Las Vegas.
  • Additionally, our e-commerce website platform continues to enhance the acceleration of marketing, distribution channels, collaborations, and sales to both professional and retail segments.

On Target Laboratories Founder Philip Low Receives Legacy Award from the American Lung Association

Retrieved on: 
Monday, April 1, 2024
Lung cancer, ALA, Organization, Innovation, Biotechnology, Disease, Cancer, Health, Patient, Legacy Award, Research, Laboratory, Surgeon, CVS Health, Prognosis, Purdue University

WEST LAFAYETTE, Ind., April 1, 2024 /PRNewswire/ -- Dr. Philip S. Low, Founder and Chief Science Officer of On Target Laboratories, Inc., will receive the Indiana American Lung Association's (ALA) Legacy Award for his lifetime and innovative work on targeted molecules. The annual Indiana ALA Legacy Award is given to individuals or organizations whose accomplishments are contributing to ending lung cancer and will be presented to Dr. Low at the ALA's "Evening of Promise Gala" in Indianapolis on Saturday, April 13. 

Key Points: 
  • Founder and Purdue University researcher Philip Low to be recognized for his invention of CYTALUX, a fluorescent targeted molecule that illuminates lung cancer cells during surgery
    WEST LAFAYETTE, Ind., April 1, 2024 /PRNewswire/ -- Dr. Philip S. Low, Founder and Chief Science Officer of On Target Laboratories, Inc., will receive the Indiana American Lung Association's (ALA) Legacy Award for his lifetime and innovative work on targeted molecules.
  • Dr. Low invented CYTALUX as part of his founding work with On Target Laboratories, a privately held biotechnology company whose mission is to illuminate cancer so it can be removed completely.
  • "We are proud that our Founder and Chief Science Officer, Dr. Low, is being celebrated for his dedication and innovative work to illuminate cancer during surgery," said Ben Lundgren, Chief Executive Officer of On Target Laboratories.
  • "I am honored to be receiving this year's Legacy Award from the Indiana American Lung Association," said Dr. Low.

Immix Biopharma 12 Month Review Progress Update

Retrieved on: 
Wednesday, February 21, 2024
Boston University, Research, Autoimmune disease, Toxicity, Doctor of Philosophy, Boston Medical Center, PMID, Health, Multiple myeloma, Patient, Poster, Blood, Investigational New Drug, Presentation, Bank, Johnson & Johnson, GMP, BCMA, Amyloidosis, BioMarin Pharmaceutical, Autoimmunity, MBBS, Pfizer, ASH, European, IMS, Conference, ODD, Haematologica, IND, Public, Gene, MD, FDA, Food, U.S. FDA, Cell, ALA, Letter, Society, Publication, BMC, Pharmaceutical industry

LOS ANGELES, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced its 12-month progress update including shareholder letter.

Key Points: 
  • LOS ANGELES, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced its 12-month progress update including shareholder letter.
  • “The past 12 months have seen landmark achievements for Immix Biopharma, cementing our position as a leading cell therapy company in autoimmune disease.
  • NXC-201 is the first and only ‘Single-Day CRS‘ CAR-T, a critical advancement for autoimmune diseases like AL Amyloidosis,” said Ilya Rachman, MD PhD CEO Immix Biopharma.
  • As we reflect on the last 12 months of progress, we wish to connect with you offering an update on Immix Biopharma.

Elevate Your Morning Ritual with Elmhurst 1925's Multi-Serve Lattes - Where Clean Ingredients and Rich Coffee Flavors Unite!

Retrieved on: 
Wednesday, February 28, 2024
Women, Fitness & Nutrition, Supermarket, Men, Family, Food, Beverage, Health, Consumer, Retail, Sprouts, Love, Kroger, Thrive Market, Erewhon, Multimedia, Steam, Carrageenan, Caffeine, Grain, ALA, The Fresh Market, Dietary fiber, Plant, Grain boundary strengthening, Ice, Orthodox Union Kosher, Milk, Tree, Coffee, Hydroelectricity, Amazon (company), Oil, Amazon, Bristol Farms, Recycling, SRP, PCR, FSC, Sprout, Vanilla, Water

Like all Elmhurst products, they contain minimal ingredients and are free from gums, oils and added fillers.

Key Points: 
  • Like all Elmhurst products, they contain minimal ingredients and are free from gums, oils and added fillers.
  • Plus, each 24 oz carton contains (2) 12 oz servings, so consumers can enjoy multiple lattes or share with a friend.
  • "This commitment to continuous innovation has led us to craft the ultimate dairy-free lattes for coffee lovers.
  • Unlike other plant-based lattes made with unnecessary preservatives, artificial flavors, carrageenan, gums, fillers, oils and emulsifiers, Elmhurst’s are crafted with only the simplest ingredients.

Submissions Now Open for the 2024 John Cotton Dana Awards

Retrieved on: 
Tuesday, March 5, 2024
American Library Association, Marketing, Library, JCD, Archive, ALA, Research

IPSWICH, Mass., March 5, 2024 /PRNewswire-PRWeb/ -- The American Library Association (ALA) is now accepting submissions for the 2024 John Cotton Dana Award (JCD). The John Cotton Dana Award is one of the most prestigious awards given to up to eight libraries. The $10,000 awards will be provided by the H.W. Wilson Foundation and honors outstanding library public relations.

Key Points: 
  • Wilson Foundation ~
    IPSWICH, Mass., March 5, 2024 /PRNewswire-PRWeb/ -- The American Library Association (ALA) is now accepting submissions for the 2024 John Cotton Dana Award (JCD).
  • The John Cotton Dana Award is one of the most prestigious awards given to up to eight libraries.
  • The John Cotton Dana Award is one of the most prestigious awards given to up to eight libraries.
  • Libraries of all types and sizes are encouraged to submit entries for a John Cotton Dana Award.

RxBenefits Appoints Mark Campbell as Chief Pharmacy Officer

Retrieved on: 
Tuesday, January 30, 2024
Growth, Knowledge, Medicine, ALA, University, Patient, Safety, PBO, Doctor of Pharmacy, Investment, Health, Nursing

BIRMINGHAM, ALA., Jan. 30, 2024 (GLOBE NEWSWIRE) -- RxBenefits , the employee benefits industry’s first technology-enabled pharmacy benefits optimizer (PBO) , today announced Mark Campbell , PharmD, has been appointed to the company’s new Chief Pharmacy Officer position.

Key Points: 
  • BIRMINGHAM, ALA., Jan. 30, 2024 (GLOBE NEWSWIRE) -- RxBenefits , the employee benefits industry’s first technology-enabled pharmacy benefits optimizer (PBO) , today announced Mark Campbell , PharmD, has been appointed to the company’s new Chief Pharmacy Officer position.
  • Campbell, whose experience covers an impressive 27-year career in the pharmacy industry, has led RxBenefits’ Clinical Services team since 2017.
  • As Chief Pharmacy Officer, Campbell will increase the company’s focus on using pharmaceutical insights to help facilitate better health outcomes.
  • With his promotion, Campbell became the fifth member of RxBenefits’ C-suite, joining Barnes – to whom he now reports – as well as President and Chief Operating Officer Robert Gamble, Chief Financial Officer Thad Kwiatkowski, and Chief Client Officer Nathan White.

Lerner Publishing Group Receives Eight American Library Association Youth Media Awards

Retrieved on: 
Monday, January 22, 2024
Life, Bear, Retirement, Light, School Library Journal, ERICA, ALA, Book, Lerner, BALL, Sydney Taylor, Shelf Awareness, Booklist, MOON, Kirkus Reviews, American Library Association, Rabbi, PICTURE, BEAR, Picture Book, Sydney Taylor Book Award, Kar-Ben Publishing, Autobiography, Elegance, Slavery, Heart, Lerner Publishing Group, Literature, Publishers Weekly, USBBY, Moon, YALSA

The ALA awards were announced over the weekend and at the Youth Media Awards ceremony during the LibLearnX conference in Baltimore.

Key Points: 
  • The ALA awards were announced over the weekend and at the Youth Media Awards ceremony during the LibLearnX conference in Baltimore.
  • As publisher at Kar-Ben Publishing, an imprint of Lerner Publishing Group, for the last twenty years, Joni has greatly increased the reach of Jewish children’s literature by producing a significant number of high-quality titles on an ever-expanding variety of Jewish topics.
  • Her efforts have put Jewish books in the eyes of the public and the hands of children on a new scale.
  • “Lerner Publishing Group is honored to receive eight ALA awards and honors in the same year,” said Adam Lerner, Publisher and CEO of Lerner Publishing Group.

Atlanta University Center (AUC) Library CEO & Director, Loretta Parham to Retire This Year

Retrieved on: 
Thursday, January 25, 2024
Knowledge, Carnegie library, Student, Research, Spelman College, ALA, African Americans, Manuscript, OCLC, Interdenominationalism, Female, Faculty, Clark Atlanta University, History, Initiative, Trustee, Strategic planning, AUC, Morehouse College, ACRL, SOLINET, National academy, Retirement, Archive, Chicago Public Library, Library, Book

ATLANTA, Jan. 25, 2024 /PRNewswire/ -- Loretta Parham, chief executive officer and director of the Robert W. Woodruff Library of the Atlanta University Center Inc., will retire after 19 years of outstanding leadership of the Library.

Key Points: 
  • ATLANTA, Jan. 25, 2024 /PRNewswire/ -- Loretta Parham, chief executive officer and director of the Robert W. Woodruff Library of the Atlanta University Center Inc., will retire after 19 years of outstanding leadership of the Library.
  • The Board of Trustees and governing body of the AUC Woodruff Library is announcing her planned retirement date of June 2024.
  • Parham received her master's degree from the University of Michigan and her bachelor's degree from Southern Illinois University.
  • The Library's Board of Trustees will launch a national executive search for the next AUC Woodruff Library CEO and Director.

RxBenefits Partners with Springbuk in Innovative New Health Intelligence Marketplace for Employers and Benefits Advisors

Retrieved on: 
Tuesday, January 16, 2024
Partnership, Pharmacy, PBO, Safety, ALA, Health, Risk management

BIRMINGHAM, ALA., Jan. 16, 2024 (GLOBE NEWSWIRE) -- RxBenefits , the employee benefits industry’s first technology-enabled pharmacy benefits optimizer (PBO) , today announced a strategic partnership with Springbuk , the leading health intelligence platform for employers and benefits advisors.

Key Points: 
  • BIRMINGHAM, ALA., Jan. 16, 2024 (GLOBE NEWSWIRE) -- RxBenefits , the employee benefits industry’s first technology-enabled pharmacy benefits optimizer (PBO) , today announced a strategic partnership with Springbuk , the leading health intelligence platform for employers and benefits advisors.
  • The Springbuk Activate marketplace matches employers with potential partners using underlying plan data, including their population's health needs or risks, showing them potential opportunities in savings and program engagement – all in one place.
  • Integrating RxBenefits’ pharmacy benefit optimization with information in the Springbuk Activate partner marketplace will create a conduit to enhance healthcare outcomes through data-driven insights and personalized care.
  • “Employers need sustainable ways to manage healthcare costs, without negatively impacting member health and safety,” said Wendy Barnes, CEO of RxBenefits .

New Research Shows Potential Benefits of Swapping Some Meat Intake with Walnuts

Retrieved on: 
Tuesday, January 9, 2024
Well, Mortality, BMC Medicine, Alpha-Linolenic acid, Patient, Meal, Research, ALA, Meta-analysis, Collection, Diet, Nut, Meat, Magnesium, Bias, NHANES, Risk, National Health, Medicine, Eating, Quality, Type 2 diabetes, Grain boundary strengthening, Vegetable, RDN, Copper, Cholesterol, Doctor of Public Health, Cardiovascular disease, Dietary fiber, Red meat, Dietary supplement

FOLSOM, Calif., Jan. 9, 2024 /PRNewswire/ -- Food trends are constantly evolving and one of the most exciting trends for 2024 is focused on putting the "plant" back in "plant-based".1

Key Points: 
  • Walnuts also have the ability to take on the texture and consistency of ground meat, allowing for seamless integration into a variety of recipes.
  • The researchers used data from the 2015 - 2018 National Health and Nutrition Examination Survey (NHANES), to model the nutrient intake of the US population with and without walnuts.
  • Specifically, 0.5, 1, 1.5 and 2 ounces of walnuts per day replaced 1, 2, 3 and 4 ounces of meat.
  • Important to note: all age and gender groups maintained vitamin B12 intake above the recommended daily allowance when replacing 2–3 ounces of meat with walnuts.